Literature DB >> 21177918

Induction of foot-and-mouth disease virus-specific cytotoxic T cell killing by vaccination.

Jared R Patch1, Lasse E Pedersen, Felix N Toka, Mauro Moraes, Marvin J Grubman, Morten Nielsen, Gregers Jungersen, Soren Buus, William T Golde.   

Abstract

Foot-and-mouth disease (FMD) continues to be a significant threat to the health and economic value of livestock species. This acute infection is caused by the highly contagious FMD virus (FMDV), which infects cloven-hoofed animals, including large and small ruminants and swine. Current vaccine strategies are all directed toward the induction of neutralizing antibody responses. However, the role of cytotoxic T lymphocytes (CTLs) has not received a great deal of attention, in part because of the technical difficulties associated with establishing a reliable assay of cell killing for this highly cytopathic virus. Here, we have used recombinant human adenovirus vectors as a means of delivering FMDV antigens in a T cell-directed vaccine in pigs. We tested the hypothesis that impaired processing of the FMDV capsid would enhance cytolytic activity, presumably by targeting all proteins for degradation and effectively increasing the class I major histocompatibility complex (MHC)/FMDV peptide concentration for stimulation of a CTL response. We compared such a T cell-targeting vaccine with the parental vaccine, previously shown to effectively induce a neutralizing antibody response. Our results show induction of FMDV-specific CD8(+) CTL killing of MHC-matched target cells in an antigen-specific manner. Further, we confirm these results by MHC tetramer staining. This work presents the first demonstration of FMDV-specific CTL killing and confirmation by MHC tetramer staining in response to vaccination against FMDV.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21177918      PMCID: PMC3067366          DOI: 10.1128/CVI.00417-10

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  56 in total

1.  Discrimination of different subsets of cytolytic cells in pseudorabies virus-immune and naive pigs.

Authors:  T G de Bruin; E M van Rooij; Y E de Visser; J J Voermans; J N Samsom; T G Kimman; A T Bianchi
Journal:  J Gen Virol       Date:  2000-06       Impact factor: 3.891

2.  Inhibition of L-deleted foot-and-mouth disease virus replication by alpha/beta interferon involves double-stranded RNA-dependent protein kinase.

Authors:  J Chinsangaram; M Koster; M J Grubman
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

Review 3.  Foot-and-mouth disease.

Authors:  Marvin J Grubman; Barry Baxt
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

4.  Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.

Authors:  G A Mayr; J Chinsangaram; M J Grubman
Journal:  Virology       Date:  1999-10-25       Impact factor: 3.616

5.  Induction of lymphopenia and inhibition of T cell function during acute infection of swine with foot and mouth disease virus (FMDV).

Authors:  Elida M Bautista; Geoffrey S Ferman; William T Golde
Journal:  Vet Immunol Immunopathol       Date:  2003-03-20       Impact factor: 2.046

6.  Immune responses and protection against foot-and-mouth disease virus (FMDV) challenge in swine vaccinated with adenovirus-FMDV constructs.

Authors:  G A Mayr; V O'Donnell; J Chinsangaram; P W Mason; M J Grubman
Journal:  Vaccine       Date:  2001-02-28       Impact factor: 3.641

7.  Leader protein of foot-and-mouth disease virus is required for cleavage of the p220 component of the cap-binding protein complex.

Authors:  M A Devaney; V N Vakharia; R E Lloyd; E Ehrenfeld; M J Grubman
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

8.  Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24.

Authors:  M P Moraes; G A Mayr; P W Mason; M J Grubman
Journal:  Vaccine       Date:  2002-02-22       Impact factor: 3.641

9.  Location of neutralizing epitopes defined by monoclonal antibodies generated against the outer capsid polypeptide, VP1, of foot-and-mouth disease virus A12.

Authors:  B H Robertson; D O Morgan; D M Moore
Journal:  Virus Res       Date:  1984-09       Impact factor: 3.303

Review 10.  Membrane markers of the immune cells in swine: an update.

Authors:  Laurence Piriou-Guzylack; Henri Salmon
Journal:  Vet Res       Date:  2008-07-19       Impact factor: 3.683

View more
  19 in total

Review 1.  Advances in swine immunology help move vaccine technology forward.

Authors:  Michael P Murtaugh
Journal:  Vet Immunol Immunopathol       Date:  2014-02-23       Impact factor: 2.046

2.  Preferred SLA class I/class II haplotype combinations in German Landrace pigs.

Authors:  Ulrike Gimsa; Chak-Sum Ho; Sabine E Hammer
Journal:  Immunogenetics       Date:  2016-08-02       Impact factor: 2.846

3.  Inoculation of swine with foot-and-mouth disease SAP-mutant virus induces early protection against disease.

Authors:  Fayna Díaz-San Segundo; Marcelo Weiss; Eva Pérez-Martín; Camila C Dias; Marvin J Grubman; Teresa de los Santos
Journal:  J Virol       Date:  2011-11-23       Impact factor: 5.103

4.  Characterization of cytotoxic T lymphocyte function after foot-and-mouth disease virus infection and vaccination.

Authors:  Jared R Patch; Mary Kenney; Juan M Pacheco; Marvin J Grubman; William T Golde
Journal:  Viral Immunol       Date:  2013-07-05       Impact factor: 2.257

5.  Assessment of the phenotype and functionality of porcine CD8 T cell responses following vaccination with live attenuated classical swine fever virus (CSFV) and virulent CSFV challenge.

Authors:  Giulia Franzoni; Nitin V Kurkure; Daniel S Edgar; Helen E Everett; Wilhelm Gerner; Kikki B Bodman-Smith; Helen R Crooke; Simon P Graham
Journal:  Clin Vaccine Immunol       Date:  2013-08-21

6.  A modern approach for epitope prediction: identification of foot-and-mouth disease virus peptides binding bovine leukocyte antigen (BoLA) class I molecules.

Authors:  Mital Pandya; Michael Rasmussen; Andreas Hansen; Morten Nielsen; Soren Buus; William Golde; John Barlow
Journal:  Immunogenetics       Date:  2015-11       Impact factor: 2.846

7.  Porcine major histocompatibility complex (MHC) class I molecules and analysis of their peptide-binding specificities.

Authors:  Lasse Eggers Pedersen; Mikkel Harndahl; Michael Rasmussen; Kasper Lamberth; William T Golde; Ole Lund; Morten Nielsen; Soren Buus
Journal:  Immunogenetics       Date:  2011-07-08       Impact factor: 2.846

8.  Identification of cytotoxic T lymphocyte epitopes on swine viruses: multi-epitope design for universal T cell vaccine.

Authors:  Yu-Chieh Liao; Hsin-Hung Lin; Chieh-Hua Lin; Wen-Bin Chung
Journal:  PLoS One       Date:  2013-12-17       Impact factor: 3.240

Review 9.  Peptide-Based Vaccines: Foot-and-Mouth Disease Virus, a Paradigm in Animal Health.

Authors:  Mar Forner; Rodrigo Cañas-Arranz; Sira Defaus; Patricia de León; Miguel Rodríguez-Pulido; Llilianne Ganges; Esther Blanco; Francisco Sobrino; David Andreu
Journal:  Vaccines (Basel)       Date:  2021-05-08

10.  Proteome-wide screening reveals immunodominance in the CD8 T cell response against classical swine fever virus with antigen-specificity dependent on MHC class I haplotype expression.

Authors:  Giulia Franzoni; Nitin V Kurkure; Sabine E Essler; Miriam Pedrera; Helen E Everett; Kikki B Bodman-Smith; Helen R Crooke; Simon P Graham
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.